Xalkori Gets FDA Breakthrough Therapy Designation for NSCLC Indication. Issue 10 (25th May 2015)

Record Type:: Journal Article
Title:: Xalkori Gets FDA Breakthrough Therapy Designation for NSCLC Indication. Issue 10 (25th May 2015)
Main Title:: Xalkori Gets FDA Breakthrough Therapy Designation for NSCLC Indication
Abstract:
Is Part Of:: Oncology times. Volume 37:Issue 10(2015:May)
Journal:: Oncology times
Issue:: Volume 37:Issue 10(2015:May)
Issue Display:: Volume 37, Issue 10 (2015)
Year:: 2015
Volume:: 37
Issue:: 10
Issue Sort Value:: 2015-0037-0010-0000
Page Start:
Page End:
Publication Date:: 2015-05-25
Subjects:: Oncology -- Periodicals
Cancer -- Periodicals
Cancer
Oncology
Periodicals
616.944
Journal URLs:: http://www.oncology-times.com/ ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:: 10.1097/01.COT.0000466417.91878.94 ↗
Languages:: English
ISSNs:: 0276-2234
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 6256.984000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 4185.xml